Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries (OP: MDXXF ) 0.0639 -0.0044 (-6.44%) Streaming Delayed Price Updated: 12:04 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,000 Open 0.0639 Bid (Size) N/A (0) Ask (Size) N/A (0) Prev. Close 0.0683 Today's Range 0.0639 - 0.0639 52wk Range 0.0476 - 0.3500 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News PharmAla Biotech To Supply MDMA For Harvard's Maclean Hospital Clinical Trial October 02, 2024 PharmAla Biotech to supply MDMA for a clinical trial at Harvard's Maclean Hospital. Company also explores European distribution at CPHI Milan Conference. Via Benzinga PharmAla Biotech Partners With Johns Hopkins University For MDMA Clinical Trials, Terminates Red Light Holland Contract September 11, 2024 PharmAla Biotech partners with Johns Hopkins to supply MDMA for clinical trials, terminates contract with Red Light Holland, and presents new APA-01 research at the EBPS Workshop. Via Benzinga Performance YTD -66.54% -66.54% 1 Month +6.50% +6.50% 3 Month -27.80% -27.80% 6 Month -55.13% -55.13% 1 Year -66.54% -66.54% More News Read More PharmAla Launches MDMA Clinical Trial Tool for Researchers August 22, 2024 From PharmAla Biotech Via GlobeNewswire PharmAla Comments on USFDA Decision regarding MDMA-Assisted Therapy and Announces Patent Granting for ALA-002 August 09, 2024 From PharmAla Biotech Via GlobeNewswire Canadian Biotech Duo Hits Psilocybin Extraction Milestone For API Development At Scale May 29, 2024 Via Benzinga Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More April 17, 2024 Via Benzinga Cortexa Commences Manufacturing GMP LaNeo™ MDMA in Australia April 05, 2024 From PharmAla Biotech Via GlobeNewswire Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More March 30, 2024 Via Benzinga Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga PharmAla's Novel MDMA Mixture Awarded US Patent, Enabling IP Protection And Further Development March 27, 2024 Via Benzinga Topics Intellectual Property Exposures Intellectual Property Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office March 27, 2024 From PharmAla Biotech Via GlobeNewswire Two Top Biotechs Forge MDMA Supply Deals For Clinical Research March 26, 2024 Via Benzinga Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office March 20, 2024 From PharmAla Biotech Via GlobeNewswire Cortexa Leads the World in First Supply of Psilocybin Under the TGA’s Authorized Prescriber Scheme March 18, 2024 From PharmAla Biotech Via GlobeNewswire Truffles To Market: Red Light Holland Wants To Develop Psilocybin API At Scale March 11, 2024 Via Benzinga Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More February 15, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.